Tris Pharma supplying Dyanavel XR amid Adderall shortage

Tris Pharma announced that Dyanvel XR (amphetamine) tablets for oral use, CII and Dyanavel XR (amphetamine) oral suspension, CII are stocked by wholesalers and continue to be available in pharmacies.

Dyanavel XR was approved by the Food and Drug Administration for the treatment of Attention-Deficit Hyperactivity Disorder in patients aged 6 years old and older. Dyanavel XR may be an option for healthcare providers and patients who can no longer fill their prescription of Adderall due to a stocking shortage, the company said. 

[Read more: Tris Pharma acquires FDA OK for Dyanavel]

"With the innovative Tris portfolio of ADHD products, we are committed to help providers and patients through their treatment journey. Dyanavel XR tablet and Dyanavel XR oral suspension provide quality treatment options for adult and pediatric patients 6 years and older with ADHD who need an amphetamine,” said James Hackworth, president of Tris branded products division.